No Data
No Data
Huaxi: Maintains AUSNUTRIA (01717) "Shareholding" rating. The milk powder continues to show an adjustment trend.
Huaxi has lowered its revenue forecast for AUSNUTRIA for the years 2024-2026 from 7.9/8.4/8.9 billion yuan to 7.7/8.1/8.5 billion yuan.
Insider Buys Additional CN¥1.0m In Ausnutria Dairy Stock
[Brokerage Focus] Everbright maintains a "Shareholding" rating for AUSNUTRIA (01717), indicating that there is still growth potential for the company in the medium to long term.
Jinwu Financial News | Everbright Securities research indicates that goat milk powder is the advantageous Business of AUSNUTRIA (01717), and the goat milk powder Industry outperforms cow milk powder. Looking at the full year of 2024, despite fierce competition in the domestic market, it is expected that domestic goat milk powder revenue will achieve year-on-year growth due to contributions from new products; overseas goat milk powder is expected to maintain a revenue growth rate of over 50% in the first half of 2024. Overseas goat milk powder performs outstandingly, with series one Kabrita infant formula smoothly launched in the USA and Canada; series two shows continuous improvement in sales performance in the Middle East market as goat milk powder acceptance and market penetration increase. The bank anticipates that in the second half of 2024, the company's cow milk powder Business revenue will
AUSNUTRIA (01717) spent 0.048 million Hong Kong dollars on January 10 to repurchase 0.026 million shares.
AUSNUTRIA (01717) announced that it will spend 0.048 million Hong Kong dollars to repurchase shares amounting to 0.026 million on January 10, 2025...
AUSNUTRIA (01717) spent 0.0148 million Hong Kong dollars to repurchase 8,000 shares on January 8.
AUSNUTRIA (01717) announced that on January 8, 2025, it will spend 0.0148 million Hong Kong dollars to repurchase 8,000 shares...
On January 3, AUSNUTRIA (01717.HK) spent HKD 0.0916 million to repurchase 0.049 million shares.
Gelonghui, January 3: AUSNUTRIA (01717.HK) announced that on January 3, 2025, it spent 0.0916 million HKD to repurchase 0.049 million shares, with a repurchase price of 1.87 HKD per share.
No Data